Stebėti
Neus Ferrer Miralles
Neus Ferrer Miralles
Titular d'universitat
Patvirtintas el. paštas uab.cat
Pavadinimas
Cituota
Cituota
Metai
Microbial factories for recombinant pharmaceuticals
N Ferrer-Miralles, J Domingo-Espín, JL Corchero, E Vázquez, ...
Microbial cell factories 8, 1-8, 2009
6112009
Recombinant pharmaceuticals from microbial cells: a 2015 update
L Sanchez-Garcia, L Martín, R Mangues, N Ferrer-Miralles, E Vázquez, ...
Microbial cell factories 15, 1-7, 2016
3802016
Side effects of chaperone gene co-expression in recombinant protein production
M Martínez-Alonso, E García-Fruitós, N Ferrer-Miralles, U Rinas, ...
Microbial cell factories 9, 1-6, 2010
1362010
Bacterial cell factories for recombinant protein production; expanding the catalogue
N Ferrer-Miralles, A Villaverde
Microbial cell factories 12, 1-4, 2013
1192013
Intracellular CXCR4+ cell targeting with T22-empowered protein-only nanoparticles
U Unzueta, MV Céspedes, N Ferrer-Miralles, I Casanova, J Cedano, ...
International journal of nanomedicine, 4533-4544, 2012
1162012
Membrane-active peptides for non-viral gene therapy: making the safest easier
N Ferrer-Miralles, E Vázquez, A Villaverde
Trends in biotechnology 26 (5), 267-275, 2008
1112008
In Vivo Architectonic Stability of Fully de Novo Designed Protein-Only Nanoparticles
MV Céspedes, U Unzueta, W Tatkiewicz, A Sanchez-Chardi, ...
ACS nano 8 (5), 4166-4176, 2014
1012014
Bacterial inclusion bodies are industrially exploitable amyloids
A De Marco, N Ferrer-Miralles, E Garcia-Fruitós, A Mitraki, S Peternel, ...
FEMS microbiology reviews 43 (1), 53-72, 2019
952019
BBB-targeting, protein-based nanomedicines for drug and nucleic acid delivery to the CNS
H Peluffo, U Unzueta, ML Negro-Demontel, Z Xu, E Váquez, ...
Biotechnology advances 33 (2), 277-287, 2015
942015
Nanostructured antimicrobial peptides: The last push towards clinics
JV Carratalá, N Serna, A Villaverde, E Vázquez, N Ferrer-Miralles
Biotechnology advances 44, 107603, 2020
842020
The nanoscale properties of bacterial inclusion bodies and their effect on mammalian cell proliferation
C Díez-Gil, S Krabbenborg, E García-Fruitós, E Vazquez, ...
Biomaterials 31 (22), 5805-5812, 2010
812010
Protein nanodisk assembling and intracellular trafficking powered by an arginine-rich (R9) peptide
E Vazquez, M Roldán, C Diez-Gil, U Unzueta, J Domingo-Espín, ...
Nanomedicine 5 (2), 259-268, 2010
792010
General introduction: recombinant protein production and purification of insoluble proteins
N Ferrer-Miralles, P Saccardo, JL Corchero, Z Xu, E García-Fruitós
Insoluble Proteins: Methods and Protocols, 1-24, 2015
782015
A new bisintercalating anthracycline with picomolar DNA binding affinity
J Portugal, DJ Cashman, JO Trent, N Ferrer-Miralles, T Przewloka, I Fokt, ...
Journal of medicinal chemistry 48 (26), 8209-8219, 2005
782005
Non-amyloidogenic peptide tags for the regulatable self-assembling of protein-only nanoparticles
U Unzueta, N Ferrer-Miralles, J Cedano, X Zikung, M Pesarrodona, ...
Biomaterials 33 (33), 8714-8722, 2012
772012
Towards protein-based viral mimetics for cancer therapies
U Unzueta, MV Céspedes, E Vázquez, N Ferrer-Miralles, R Mangues, ...
Trends in biotechnology 33 (5), 253-258, 2015
752015
Engineering protein self-assembling in protein-based nanomedicines for drug delivery and gene therapy
N Ferrer-Miralles, E Rodríguez-Carmona, JL Corchero, E Garcia-Fruitos, ...
Critical reviews in biotechnology 35 (2), 209-221, 2015
722015
Bottom-up instructive quality control in the biofabrication of smart protein materials
F Rueda, MV Céspedes, O Cochinillo, A Sanchez Chardi, ...
Advanced materials, 1-7, 2015
712015
Biological activities of histidine-rich peptides; merging biotechnology and nanomedicine
N Ferrer-Miralles, JL Corchero, P Kumar, JA Cedano, KC Gupta, ...
Microbial cell factories 10, 1-5, 2011
682011
The N-ras Proto-oncogene Can Suppress the Malignant Phenotype in the Presence or Absence of Its Oncogene
R Diaz, D Ahn, L Lopez-Barcons, M Malumbres, I Perez de Castro, J Lue, ...
Cancer research 62 (15), 4514-4518, 2002
642002
Sistema negali atlikti operacijos. Bandykite vėliau dar kartą.
Straipsniai 1–20